Lab-verified, high-potency bulk substrates tailored for anti-aging formulations, metabolic regulation, and clinical-grade health products.
Japan represents one of the most sophisticated, discerning, and strictly governed nutraceutical sectors in the world. Governed jointly by the Ministry of Health, Labour and Welfare (MHLW), the Consumer Affairs Agency (CAA), and the Pharmaceuticals and Medical Devices Agency (PMDA), the market operates across precise categorizations: Tokuho (Foods for Specified Health Uses - FOSHU), Foods with Nutrient Function Claims (FNFC), and the dynamic Kinousei Hyoji Shokuhin (Foods with Function Claims - FFC). Under the FFC system, scientific clinical substantiation (SR - Systematic Review or randomized controlled trials) allows manufacturers to claim structure-function efficacy on end-consumer packaging. Consequently, raw ingredient purity, batch-to-batch chromatographic reproducibility, and absence of unspecified adulterants are absolute prerequisites for brand survival in Tokyo, Osaka, and regional prefectures.
With more than 29% of its populace over 65 years old, Japan is the global vanguard for "Healthy Life Expectancy" (健康寿命, Kenko Jumyo). The market demand has shifted dramatically from general multi-vitamins toward target-specific bio-molecules: cellular senolytics, sirtuin activators (such as Β-NMN and NAD+), cognitive lipid matrices (Phosphatidylserine), joint fluidity protectors (SAMe), and vascular micro-circulatory co-factors.
A foundational hurdle for Japanese ingredient importers is navigating the Shokuyaku Kubun list (classification of non-medicinal herbs and chemicals). Compounds designated strictly as "drug substances" cannot be incorporated into health supplements. Ensuring that ingredients like Melatonin, Indole-3-Carbinol, and Serrapeptase adhere strictly to compliant botanical pathways, export designations, or bonded international processing enables OEM/ODM manufacturers to avoid customs quarantine rejections.
While Japanese research institutions pioneer clinical validation and consumer packaging aesthetics, domestic synthesis and extraction at industrial scales face severe constraints regarding land, chemical precursors, and energy expenditure. Xi'an Le-Nutra Ingredients bridges this gap by acting as an integrated upstream manufacturing partner. Operating a massive 60,000 m² cGMP extraction facility equipped with multi-stage countercurrent extraction batteries and advanced enzymatic synthesis suites, Le-Nutra supplies raw materials that meet Japanese Japanese Pharmacopoeia (JP) criteria, United States Pharmacopeia (USP), and European Pharmacopoeia (EP) specifications at significant economies of scale.
Comprehensive analytical specifications engineered to meet Japanese importing protocols and global food formulation criteria.
| Ingredient Nomenclature | CAS Identity | Assay Method & Standard | Primary Japanese Market Target | Solubility & Dosage Format |
|---|---|---|---|---|
| Β-Nicotinamide Mononucleotide (NMN) | 1094-61-7 | ≥99.5% by HPLC (Enzymatic) | Cellular anti-aging, NAD+ salvage, mitochondrial vitality | Water soluble (100mg/mL); sublingual tablets, functional jelly |
| S-Adenosyl-L-Methionine (SAMe) | 29908-03-0 | ≥50.0% SAM-ion content | Cartilage maintenance, methylation balance, neuro-support | Enteric-coated capsules, humidity-protected blister strips |
| D-Mannose Micronized | 3458-28-4 | ≥99.0% by HPLC / Optical Rotation | Urinary tract microbiome, mucosal bacterial clearance | Instant dry stick-packs, functional powder beverages |
| Phosphatidylserine (PS) 50% | 51446-62-9 | ≥50.0% PS by HPLC (Soy / Sunflower) | Cognitive focus, memory preservation, brain cell signaling | Lipid suspension softgels, powdered meal replacement shakes |
| Coenzyme Q10 (Ubiquinone) | 303-98-0 | ≥98.0%–101.0% by HPLC (Fermented) | Cardiovascular dynamics, cellular ATP synthesis, nutricosmetics | Oil dispersions, self-emulsifying softgels, nano-emulsions |
| 3,3'-Diindolylmethane (DIM) | 1961-72-5 | ≥99.0% by HPLC / GC | Estrogen metabolism balance, phase II liver detoxification | Liposomal blends, standard hard-shell gelatin or HPMC capsules |
| Serrapeptase (Enteric Active) | 37312-62-2 | ≥2,000 to 20,000 U/mg Enzymatic Assay | Systemic inflammation, fibrin clearance, ENT recovery | Time-release enteric pellets, targeted gastro-resistant formulations |
How Le-Nutra's modernized manufacturing complex in Xi'an delivers irreproachable quality and cost efficiency to brand owners worldwide.
Operating six high-throughput production lines with 3,000 metric tons of annual processing capacity, our Xi'an infrastructure accommodates both continuous industrial bulk runs and tailored custom synthesis batches with automated real-time process monitoring.
Departing from obsolete harsh chemical syntheses, our Β-NMN, NAD+, and cofactors utilize biological enzymatic catalytic pathways. This biological method ensures 100% pure β-anomer stereospecificity, virtually zero solvent residues, and an environmentally sustainable carbon footprint.
Every single batch exported to Tokyo, Kobe, or international ports is paired with comprehensive multi-technique documentation: HPLC/LC-MS purity verification, heavy metals down to ppb limits (ICP-MS), residual solvents via GC-HS, and full microbiology reports.
Adapting raw ingredients to high-value consumer formats across modern Asian and Western markets.
The Japanese market favors single-serve functional jellies (Zeri) and micro-dispersible powders. Hydrolyzed fish collagen peptides, D-Mannose, and water-soluble CoQ10 are engineered with precise particle sizes (80–120 mesh) to ensure crystal-clear solubility and optimal mouthfeel without gritty precipitates.
Japan’s orthopedic community targets "Locomotive Syndrome" (loss of mobility). By pairing pure SAMe with specialized vegetal proteins, branched-chain amino acids (BCAAs), and Serrapeptase, contract manufacturers produce multi-tiered tablets that simultaneously target cartilage recovery, myofibrillar preservation, and localized inflammation.
With the rapid adoption of stress-reduction and sleep architecture claims under the FFC umbrella, formulations integrating Phosphatidylserine, Melatonin (export-bonded processing), and high-purity Cynarin (Artichoke extract) are booming across cross-border e-commerce (Rakuten, Yahoo Japan, Amazon JP).
Essential checklist for quality control directors, regulatory affairs executives, and procurement managers.
In advanced cofactors such as NMN and SAMe, chemical synthesis often generates racemic mixtures containing inactive or deleterious stereoisomers (α-NMN vs. biologically active β-NMN). Qualified suppliers must supply validated Optical Rotation and high-resolution 1H-NMR data proving exclusive enantiomeric purity to satisfy Japanese Ministry import reviews.
Japanese Food Sanitation Act limits for Lead (Pb ≤ 1.0 ppm), Arsenic (As ≤ 1.0 ppm), Cadmium (Cd ≤ 0.5 ppm), and Mercury (Hg ≤ 0.1 ppm) are far more rigorous than standard international thresholds. Our Xi'an batch releases are validated using ICP-MS down to parts-per-billion sensitivity.
Use of Class 1 and Class 2 solvents during extraction is strictly circumscribed. Xi'an Le-Nutra utilizes food-grade ethanol and deionized ultrafiltration water, eliminating toxic traces of methanol, dichloromethane, or n-hexane from all finished crystalline powders.
Active enzymes like Serrapeptase and unstable salts like SAMe degrade rapidly in humidity. Our export packaging features pharma-grade multi-layer heat-sealed aluminum foil pouches filled with high-purity inert nitrogen, backed by desiccant inserts and temperature data loggers for all sea and air freight consignments into Tokyo and Osaka ports.
Critical regulatory, operational, and supply questions answered by our international technical team.
We provide exhaustive Systematic Review (SR) raw data packages, chromatographic fingerprinting, quantitative active marker assays (HPLC/UV), stability testing data (accelerated and long-term), and rigorous batch consistency evidence across at least three distinct industrial runs to substantiate the safety and efficacy prerequisites demanded by Japan’s Consumer Affairs Agency.
Air freight shipments (ideal for high-value compounds like Β-NMN, NAD+, and peptides) typically arrive at Narita (NRT) or Kansai (KIX) within 48 to 72 hours, complete with pre-cleared electronic manifests. Bulk maritime container cargo (D-Mannose, plant proteins, herbal extracts) departs from Qingdao or Shanghai port and reaches Tokyo or Yokohama in 5 to 7 transit days.
Yes. We offer precision air-jet milling to achieve ultra-fine micronization from 80 mesh up to 500 mesh (D90 < 20 μm) for instant beverage powders, sublingual tablet applications, or smooth cosmetic suspensions. In addition, fluid-bed granulation is available to create direct-compressible (DC) grades for high-speed automated tableting machinery.
Our multi-functional production lines operate in strict adherence to ISO 9001, ISO 22000, and cGMP standards with dedicated cleanrooms (Class 100,000 / D-grade). Analytical release testing includes screen protocols for WADA-prohibited substances, pesticide multi-residue screenings (>500 pesticides via GC-MS/MS), and heavy metals testing under validated JP/USP protocols.
Clinically validated wholesale ingredients supporting hormonal harmony, longevity, and systemic recovery across global consumer brands.
Partner with Xi'an Le-Nutra for documented, reproducible, and competitively priced dietary supplement raw materials. Fast-track qualification with audit-ready batch COAs, analytical method dossiers, and sample kits.
Typical reply within one business day (UTC+8).
[email protected] +86-29-86518603 Request a Catalog Contact us